Search Results

Prucalopride 50mg 50mg  | Purity Not Available

Adooq Bioscience

Prucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.

More Information Supplier Page

Prucalopride 5mg 5mg  | Purity Not Available

Adooq Bioscience

Prucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.

More Information Supplier Page

Prucalopride 25mg 25mg  | Purity Not Available

Adooq Bioscience

Prucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.

More Information Supplier Page

Prucalopride 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Prucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.

More Information Supplier Page

ASP3026 10mg 10mg  | Purity Not Available

Adooq Bioscience

ASP3026 is a novel and selective inhibitor for the ALK kinase. ASP3026 potently inhibited ALK kinase activity and was more selective than crizotinib in a Tyr-kinase panel.

More Information Supplier Page

ASP3026 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

ASP3026 is a novel and selective inhibitor for the ALK kinase. ASP3026 potently inhibited ALK kinase activity and was more selective than crizotinib in a Tyr-kinase panel.

More Information Supplier Page

ASP3026 25mg 25mg  | Purity Not Available

Adooq Bioscience

ASP3026 is a novel and selective inhibitor for the ALK kinase. ASP3026 potently inhibited ALK kinase activity and was more selective than crizotinib in a Tyr-kinase panel.

More Information Supplier Page